glp-1 long term risks Psychological and behavioral effects of and GIP agonists in weight loss: a comprehensive review | Journal of Diabetes & Metabolic Disorders GLP‐1 receptor agonists and muscle

This is difficult to answer without having published studies examining the effects of lower dosing

Doctors and patients alike are increasingly exploring how fractional doses can target specific metabolic and inflammatory issues without the intensity of a full weight-loss regimen

Many patients use GLP-1 injections for a set period before transitioning to maintenance support

In animal models of psychosis, liraglutide administration consistently led to a reduction of psychotic-like behavior 119,120,121 , which was also associated with increased brain-derived neurotrophic factor, CREB/p-CREB, and Trk-B expression in the hippocampus and prefrontal cortex 120 , and reduced serum and hippocampal tumor necrosis factor and oxidative stress 121